Cargando…

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020

BACKGROUND: The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using a nine-item fatigue severity scale (FSS-9) and identify the impact that clinical and sociode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vold, Jørn Henrik, Gjestad, Rolf, Aas, Christer F., Chalabianloo, Fatemeh, Skurtveit, Svetlana, Løberg, Else-Marie, Johansson, Kjell Arne, Fadnes, Lars Thore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737389/ https://www.ncbi.nlm.nih.gov/pubmed/33317568 http://dx.doi.org/10.1186/s13011-020-00334-x

Ejemplares similares

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
por: Aas, Christer Frode, et al.
Publicado: (2021)

Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
por: Vold, Jørn Henrik, et al.
Publicado: (2019)

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
por: Aas, Christer F., et al.
Publicado: (2020)

The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
por: Chalabianloo, Fatemeh, et al.
Publicado: (2021)

Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
por: Vold, Jørn Henrik, et al.
Publicado: (2022)

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
por: Aas, Christer Frode, et al.
Publicado: (2020)

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
por: Aas, Christer Frode, et al.
Publicado: (2020)

Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway
por: Madebo, Tesfaye, et al.
Publicado: (2022)

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway
por: Lygren, Ole Jørgen, et al.
Publicado: (2019)

Emotional Eating and Changes in High-Sugar Food and Drink Consumption Linked to Psychological Distress and Worries: A Cohort Study from Norway
por: Javadi Arjmand, Elaheh, et al.
Publicado: (2023)

Psychosocial characteristics differentiate non-distressing and distressing voices in 10,346 adolescents
por: Løberg, Else-Marie, et al.
Publicado: (2019)

S57. TREATMENT SATISFACTION IN ACUTE PHASE PSYCHOSIS: COMPARISON BETWEEN ANTIPSYCHOTIC NAïVE AND PREVIOUSLY MEDICATED PATIENTS
por: Stabell, Lena, et al.
Publicado: (2018)

Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)
por: Druckrey-Fiskaaen, Karl Trygve, et al.
Publicado: (2022)

Changes in Body Mass Index and Their Associations with Psychological Distress, Worries, and Emotional Eating during the COVID-19 Pandemic: A Norwegian Cohort Study
por: Arjmand, Elaheh Javadi, et al.
Publicado: (2023)

Oral health related quality of life and reasons for non‐dental attendance among patients with substance use disorders in withdrawal rehabilitation
por: Åstrøm, Anne Nordrehaug, et al.
Publicado: (2021)

Perceived consequences and worries among youth in Norway during the COVID-19 pandemic lockdown
por: Lehmann, Stine, et al.
Publicado: (2021)

S3. CHILDHOOD TRAUMA AND COGNITIVE FUNCTIONING IN SCHIZOPHRENIA SPECTRUM DISORDERS: EFFECT OF FREQUENCY AND TYPE OF CHILDHOOD TRAUMA
por: Morkved, Nina, et al.
Publicado: (2018)

S87. THE INITIAL CHANGE IN THE SERUM LEVEL OF C-REACTIVE PROTEIN IN ACUTE PSYCHOSIS IS ASSOCIATED WITH COGNITIVE PERFORMANCE IN LATER PHASES
por: Fathian, Farivar, et al.
Publicado: (2018)

Sociodemographic determinants of catch-up HPV vaccination completion between 2016-2019 in Norway
por: Van Boetzelaer, E., et al.
Publicado: (2021)

The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis
por: Johnsen, Erik, et al.
Publicado: (2016)

Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis
por: Fathian, Farivar, et al.
Publicado: (2018)

Performance of the WHOQOL-BREF among Norwegian substance use disorder patients
por: Muller, Ashley Elizabeth, et al.
Publicado: (2019)

COVID-19 survey among people who use drugs in three cities in Norway
por: Welle-Strand, Gabrielle K., et al.
Publicado: (2020)

Increased Gaming During COVID-19 Predicts Physical Inactivity Among Youth in Norway—A Two-Wave Longitudinal Cohort Study
por: Haug, Ellen, et al.
Publicado: (2022)

The association between psychological distress and alcohol consumption and physical activity: a population-based cohort study
por: Alpers, Silvia Eiken, et al.
Publicado: (2023)

Associations of Maternal Use of Benzodiazepines or Benzodiazepine-like Hypnotics During Pregnancy With Immediate Pregnancy Outcomes in Norway
por: Huitfeldt, Anders, et al.
Publicado: (2020)

Emotional Eating in Relation to Worries and Psychological Distress Amid the COVID-19 Pandemic: A Population-Based Survey on Adults in Norway
por: Bemanian, Mitra, et al.
Publicado: (2020)

T206. ANTIPSYCHOTIC EFFECTIVENESS FOCUSING ON INSIGHT
por: Stabell, Lena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k9vjvh6bdmdne9vnou4ori9mld